Key takeaways
- While the S&P 500 fell about 4.6% in Q1 2026—its worst quarter since 2022—10 names like Sandisk, Lumentum, LyondellBasell, Dow, APA, Moderna, CF Industries, Ciena, Texas Pacific Land, and Western Digital posted gains from 57% to 160%.
- These stocks rode specific narratives—AI data storage shortages, war‑driven energy and chemicals demand, and niche growth stories in biotech and networking—backed by institutional buying from value, energy, and thematic funds, even as mega‑cap growth dragged the index lower
- Owning them adds substantial volatility to a retail portfolio: they can hedge index losses when their themes are in favor, but their high beta and narrative‑driven flows can also magnify drawdowns if the macro backdrop or story turns.
- Looking ahead to 2026 as a whole, history from the early‑2000s (post‑2003 rotation out of tech into cyclicals and energy) suggests some of these winners will keep outperforming while others mean‑revert sharply, especially where gains ran far ahead of fundamentals.
- Tickeron’s AI trading bots use Financial Learning Models to track these outliers across multiple timeframes, helping retail investors decide when to ride momentum, when to trim, and how to size positions so one high‑flyer doesn’t dominate portfolio risk.
Why these 10 rallied while the S&P 500 fell
Q1 2026 was dominated by the Iran war, surging oil prices, and rising yields—macro forces that hit expensive growth stocks and major indices but boosted select cyclical and commodity names. According to market recaps, mega‑cap tech and large‑cap growth indexes lost double digits, while energy, materials, and certain “old economy” plays posted strong gains. Against that backdrop, this top‑10 list reflects three big narratives: AI storage demand, war‑driven energy and materials, and idiosyncratic growth stories.
Company‑by‑company: narratives, big backers, and why they diverged from the S&P 500
Sandisk (SNDK) +160% and Western Digital (WDC) +57%
Narrative: AI data boom and NAND shortage
Market commentary highlights that SanDisk and Western Digital led the S&P 500 due to a global NAND flash shortage driven by soaring demand for “AI at the edge”—local storage for AI‑capable phones, PCs, and smaller data‑center nodes. As investors rotated away from richly valued AI software, they looked for hardware beneficiaries that still traded at cyclical discounts.
Institutional backing:
- Semiconductor and storage‑focused funds, value managers, and some AI‑thematic ETFs increased positions in SNDK and WDC as part of a “picks and shovels for AI” trade.
Volatility impact: These stocks are high‑beta cyclical semis: they can significantly add volatility, but they also diversify away from mega‑cap software.
2026 retail outlook: If AI device demand and data‑center build‑outs persist, storage names can keep outperforming, but gains will likely moderate. A supply response or slowdown could bring 20–40% drawdowns similar to past memory cycles—retail investors who chase parabolic moves without risk rules are most at risk.
Lumentum (LITE) +90% and Ciena (CIEN) +66%
Narrative: Optical networking for AI and high‑bandwidth traffic
Lumentum and Ciena gained on expectations that AI workloads and cloud traffic will require more high‑speed optical links in and between data centers, even as broader tech sold off. Orders for coherent optics, 800G gear, and telecom upgrades re‑accelerated after a digestion phase, surprising a market that had written off the group as “old telco.
Institutional backing:
- Telecom infrastructure funds, AI infrastructure baskets, and some multi‑asset managers rotated into optical names as a relative value play within tech.
Volatility impact: These mid‑cap techs are meaningfully more volatile than the index; adding them can increase both upside and downside swings.
2026 retail outlook: As in the early‑2000s fiber cycle, strong fundamentals can coexist with big swings. If AI traffic growth remains robust, they may trend higher but with episodic 20% pullbacks tied to capex timing and customer concentration.
LyondellBasell (LYB) +86%, Dow (DOW) +78%, CF Industries (CF) +68%
Narrative: Materials and fertilizers riding energy, refinery, and ag cycles
These commodity and chemical names benefited from war‑driven energy shocks, refining margins, and fertilizer demand. As oil and gas prices rose and supply chains stayed tight, investors sought companies with tangible assets, pricing power, and healthier balance sheets than during past cycles.
Institutional backing:
- Value and dividend funds, commodity‑linked strategies, and some “inflation beneficiaries” portfolios increased positions in integrated chemicals and fertilizers as a hedge against sticky prices.
Volatility impact: They add cyclical volatility, but often move differently than tech—helping diversify a growth‑heavy portfolio.
2026 retail outlook: History from the 2003–2007 commodity cycle suggests they can keep delivering strong cash flows and dividends if energy stays firm, but they are vulnerable if the Fed overtightens or if a global slowdown hits industrial demand. Retail investors should expect a bumpier path, not a straight line up.
APA Corporation (APA) +73% and Texas Pacific Land (TPL) +65%
Narrative: Oil, gas, and land tied to war and AI power demand
War in Iran and proposed Trump energy policies pushed crude and gas higher, lifting explorers like APA and landowners like TPL. Texas Pacific Land also won attention for pivoting parts of its West Texas acreage toward hosting AI data‑center infrastructure—linking it to both the energy and AI narratives.
Institutional backing:
- Energy‑sector ETFs, real‑asset funds, and some hedge funds increased exposure to E&Ps and royalty/land plays as oil hit multi‑year highs
Volatility impact: These are very volatile: heavily exposed to commodity prices, policy risk, and, in TPL’s case, sentiment about AI infrastructure. They can act as a strong hedge against an inflationary war shock, but also swing 30–40% in both directions.
2026 retail outlook: If the Iran conflict drags on and AI‑driven power demand keeps pressure on gas, these names can remain winners. A ceasefire plus policy intervention to cap energy prices would likely mean sharp corrections—retail traders who understand they are buying cyclical hedges, not “guaranteed AI winners,” will fare better.
Moderna (MRNA) +72%
Narrative: mRNA 2.0 and new vaccine pipeline
Moderna’s rebound reflects renewed optimism about its non‑COVID pipeline—respiratory vaccines, cancer vaccines, and partnered mRNA programs—after the stock spent years correcting from pandemic highs. Positive trial data and regulatory progress shifted sentiment from “ex‑COVID bust” to “platform company” just as growth stocks elsewhere were sold on valuation fears.
Institutional backing:
- Healthcare and biotech specialists, growth funds, and some hedge funds re‑entered MRNA as a contrarian large‑cap biotech with cash, IP, and a clearer late‑stage pipeline.
Volatility impact: Large‑cap biotech can add meaningful volatility; trial and regulatory headlines can move the stock 10–20% in a session. As a portfolio component, it offers diversification (not tied to rates or energy) but demands risk sizing.
2026 retail outlook: The 2003 biotech cycle suggests a two‑way path: companies with real products and approvals can grow into valuations; those that disappoint on data can halve quickly. Retail investors should expect a news‑driven ride, not a smooth compounding path.
The main narratives and subgroups
You can group the Q1 winners into three narrative clusters that help explain their divergence from the S&P 500:
- AI and data‑infrastructure hardware
- SNDK, WDC, LITE, CIEN, TPL (AI land angle)
- Benefited from the shift from over‑owned AI software megacaps to “picks and shovels” like memory, storage, optics, and land for data centers.
- War‑driven energy, materials, and fertilizers
- LYB, DOW, APA, TPL, CF
- Gained from higher oil, gas, and chemical prices amid Iran conflict, supply disruptions, and rising power demand.
- Idiosyncratic growth / health‑care rerating
- MRNA
- A company‑specific rerating as investors re‑evaluate the long‑term mRNA platform beyond COVID.
These clusters can behave very differently from the broader index, which in Q1 was dragged down by mega‑cap growth, higher yields, and recession worries.
Do these names add or reduce portfolio volatility?
For most retail portfolios, adding these Q1 winners will increase volatility:
- They are concentrated in cyclical and thematic pockets—energy, materials, semis, and biotech—that react strongly to macro shocks.
- Many are mid‑cap or high‑beta, with large moves around earnings, data, and war headlines.
- They diversify factor exposure (more value, commodities, and idiosyncratic growth vs big tech), which can reduce correlation to mega‑caps but not overall volatility.
Used cautiously, they can hedge some downside when the S&P 500 is pulled lower by expensive growth—but they’re not low‑risk replacements for core index exposure.
2026 outlook for retail investors, with a 2003‑style rotation lens
After the 2000 bust and the 2003 Iraq build‑up, markets saw a multi‑year rotation from over‑owned tech into energy, materials, and industrials. Early adopters benefited; latecomers chasing after big quarterly winners sometimes bought near cyclical peaks.
If 2026 follows that script:
- Energy and materials (APA, TPL, LYB, DOW, CF) could continue to outperform in a higher‑for‑longer inflation regime, but with more volatility and episodic drawdowns. Retail investors who treat them as part of a diversified “real assets” sleeve, not as all‑in bets, are likely to do better.
- AI hardware plays (SNDK, WDC, LITE, CIEN, TPL) may keep gaining share of the “AI dollar” as investors broaden beyond software—but returns will depend on supply discipline and capex cycles. Expect a mix of continued strength and sharp pullbacks as expectations reset.
- MRNA could either grow into a durable “platform biotech” or see a partial giveback if key trials disappoint or timelines slip. History suggests large‑cap biotechs rarely move linearly after big rebounds.
For retail traders, the takeaway from 2003 is: rotation winners can keep compounding, but chasing quarterly leaderboards without risk controls often leads to buying late and experiencing the first big drawdown rather than the full multi‑year run.
How Tickeron’s AI trading bots use Financial Learning Models on these outliers
Managing a portfolio with names like SNDK, LITE, LYB, DOW, APA, MRNA, CF, CIEN, TPL, and WDC requires discipline. Tickeron’s platform uses Financial Learning Models (FLMs)—AI models purpose‑built for markets—to give retail traders institutional‑style tools:
- Multi‑timeframe signal generation
FLMs analyze price, volume, and volatility in these tickers across 5‑, 15‑, and 60‑minute windows, detecting trend‑following and mean‑reversion patterns. Bots then generate buy/sell signals with historical win rates and expected move statistics, so traders can decide whether to ride or fade momentum rather than guessing. - Risk‑aware position sizing and exits
AI agents incorporate stop‑loss levels, trailing exits, and max‑position limits automatically, reducing the chance that one high‑flyer (like SNDK in Q1) grows into an outsized, unmanaged risk. This is crucial when dealing with cyclical and thematic names that can reverse quickly. - Sector and factor rotation
FLM‑driven bots monitor relative performance between these winners and broader sectors (energy, materials, tech, health care) and the S&P 500. When signals show rotation slowing or reversing, bots can scale positions down or reallocate toward safer exposures, protecting gains.
For retail investors, combining a core index holding with AI‑guided tactical exposure to these Q1 outliers is one way to benefit from the themes driving them—AI infrastructure, war‑driven commodities, and mRNA—without letting any single narrative hijack the entire portfolio.
Tickeron AI Perspective